Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Aug 18, 2014 aberman michael s Officer Option Execute 8,750 52.03
Aug 18, 2014 mccorkle douglas s Officer Automatic Sell 5,875 353.00
Aug 18, 2014 mccorkle douglas s Officer Option Execute 5,875 52.03
Aug 15, 2014 brown michael s Director Automatic Sell 3,000 349.20
Aug 15, 2014 brown michael s Director Option Execute 3,000 33.42
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Aug 13, 2014 vagelos p roy Officer Sell 8,028 340.01
Aug 11, 2014 stahl neil Officer Sell 11,646 339.33 - 341.27
Aug 11, 2014 vagelos p roy Officer Sell 9,372 340.02 - 341.02
Aug 8, 2014 stahl neil Officer Sell 2,100 340.60 - 341.00
Aug 8, 2014 vagelos p roy Officer Sell 2,600 340.33
Aug 7, 2014 stahl neil Officer Sell 741 340.39 - 341.03
Aug 7, 2014 vagelos p roy Officer Disposition (Non Open Market) 142,651 340.12
Aug 7, 2014 vagelos p roy Officer Option Execute 270,352 9.49
Aug 7, 2014 van plew daniel p Officer Sell 6,806 338.37
Aug 6, 2014 goldstein joseph l Director Sell 2,000 331.20
Aug 6, 2014 stahl neil Officer Disposition (Non Open Market) 20,513 336.11
Aug 6, 2014 stahl neil Officer Option Execute 35,000 21.25
Aug 6, 2014 van plew daniel p Officer Disposition (Non Open Market) 8,194 336.11
Aug 6, 2014 van plew daniel p Officer Option Execute 15,000 21.25
Showing 41-60 of 861 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)